This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Fridtjof Lund-Johansen
Senior Scientist at Oslo University Hospital, Rikshospitalet


Fridtjof Lund-Johansen is an MD PhD with background in hematology. He has been active in flow cytometry (FCM) since 1987, and in the mid 1990s he invented FCM analysis of immuno-precipitates (IP-FCM). During the past 10 years he has transformed IP-FCM into Microsphere Affinity Proteomics (MAP) where beads with thousands of fluorescent bar codes are used to build proteome-scale assays. His current research focus is on integration of MAP and mass spectrometry (MS). Lund-Johansen is an internationally renown expert on antibody validation and works in close collaboration with many world-leading antibody manufacturers to implement MAP/MS as a pillar in antibody quality assessment.

Agenda Sessions

  • Antibody Selection and Screening in Early Discovery

  • Using Multiplexed Flow Cytometry to Screen Antibodies and Sera

    On Demand